Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Gurugram Bust: Rs 70 Lakh Counterfeit Eli Lilly Mounjaro Recovered, 2 Arrested

Copycat weight-loss drugs: Eli Lilly sues two medical spas

Written By Ruchika Sharma14 Jan 2025 5:28 PM IST

Two medical spas have been sued by Eli Lilly for selling unapproved products that claim to contain tirzepatide. Tirzepatide is the main ingredient in...

Eli Lilly to acquire Scorpion Therapeutics mutant-selective PI3Kα inhibitor program

Written By Ruchika Sharma14 Jan 2025 4:48 PM IST

Indianapolis: Eli Lilly and Company and Scorpion Therapeutics, Inc., a private biotechnology company developing small molecule...

Roche gets negative EMA Committee opinion on Elevidys CMA

Roche gets USFDA clearance for highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma

Written By Ruchika Sharma14 Jan 2025 4:06 PM IST

Basel: Roche has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its...

AstraZeneca Imfinzi approved in EU as immunotherapy for limited stage small cell lung cancer

AstraZeneca-Daiichi Sankyo Datopotamab deruxtecan gets USFDA priority review in pretreated EGFR-mutated non-small cell lung cancer

Written By Ruchika Sharma14 Jan 2025 2:30 PM IST

Datopotamab deruxtecan is a specifically engineered TROP2-directed DXd antibody drug conjugate discovered by Daiichi Sankyo.

Sanofi Sarclisa gains Chinese nod for treatment of adult patients with relapsed or refractory multiple myeloma

Written By Ruchika Sharma14 Jan 2025 1:30 PM IST

Paris: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine,...

GSK Depemokimab applications accepted for review in China, Japan for asthma with type 2 inflammation, CRSwNP

GSK to acquire IDRx for upto USD 1.15 billion

Written By Ruchika Sharma14 Jan 2025 12:45 PM IST

London: GSK plc has announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based, clinical-stage...

Wockhardt Gets 5-Year NPPA Price Control Exemption for Nafithromycin 400 mg Tablets

Zaynich shows over 97 percent efficacy for drug-resistant bacteria: Wockhardt

Written By Ruchika Sharma13 Jan 2025 1:06 PM IST

Mumbai: Wockhardt has announced that Zaynich (Zidebactam/Cefepime, WCK 5222) demonstrated over 97 percent clinical efficacy in treating...

Granules India packaging facility in US successfully completes USFDA inspection

Biocon Biologics Malaysia site classified as VAI by USFDA

Written By Ruchika Sharma13 Jan 2025 11:30 AM IST

Bengaluru: Biocon has announced that the U.S. Food and Drug Administration (FDA) has classified Biocon Biologics' Insulins facilities in...

USFDA nod to JnJ Tremfya for Crohns disease

JnJ Nipocalimab gets USFDA Priority Review designation for generalized myasthenia gravis

Written By Ruchika Sharma12 Jan 2025 3:30 PM IST

Spring House: Johnson & Johnson has announced the nipocalimab Biologics License Application (BLA) has received Priority Review designation...

Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilities

Novo Nordisk, Valo Health expand collaboration to discover, develop novel treatments for cardiometabolic diseases

Written By Ruchika Sharma12 Jan 2025 12:00 PM IST

Lexington: Novo Nordisk A/S and Valo Health, Inc. have announced they have entered into an expanded agreement to discover and develop novel...

Bayer arm Vividion Therapeutics acquires Tavros Therapeutics

Written By Ruchika Sharma12 Jan 2025 11:30 AM IST

San Diego: Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company has announced the acquisition of Tavros Therapeutics, Inc., a...

Johnson and Johnson Gets CDSCO Panel Nod for Talqetamab in Relapsed Multiple Myeloma, Phase IV Trial Mandated

JnJ temporarily pauses rollout of Varipulse heart device in US

Written By Ruchika Sharma11 Jan 2025 5:35 PM IST

Johnson & Johnson has announced a temporarily pause in the rollout of its Varipulse heart device in the United States as it investigates four...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok